Header Ads

Britain#39;s GSK to take 10% stake in Germany#39;s CureVac for $163 million

Britain#39;s GSK to take 10% stake in Germany#39;s CureVac for $163 million CureVac#39;s existing COVID-19 mRNA and rabies vaccines research programmes are not included in the deal, the companies said.

from Moneycontrol Business News https://ift.tt/2WD8SQj

No comments:

Powered by Blogger.